Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach - Test2 - elhamkhani - TriplyDB

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

http://www.wikidata.org/entity/Q24633776

about

Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer Molecular signatures from omics data: from chaos to consensus A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP)Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling PTPN14 is required for the density-dependent control of YAP1 IAPs regulate the plasticity of cell migration by directly targeting Rac1 for degradation Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ Cellular inhibitor of apoptosis protein-1 (cIAP1) can regulate E2F1 transcription factor-mediated control of cyclin transcription β-Catenin-driven cancers require a YAP1 transcriptional complex for survival and tumorigenesis Identification of RPS14 as a 5q- syndrome gene by RNA interference screen Raf family kinases: old dogs have learned new tricks 14-3-3ζ turns TGF-β's function from tumor suppressor to metastasis promoter in breast cancer by contextual changes of Smad partners from p53 to Gli2 SKI and MEL1 cooperate to inhibit transforming growth factor-beta signal in gastric cancer cells Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein TEAD mediates YAP-dependent gene induction and growth control Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls The hippo signaling pathway in development and cancer Structures of YAP protein domains reveal promising targets for development of new cancer drugs Structural and functional analysis of the YAP-binding domain of human TEAD2 miR-221 overexpression contributes to liver tumorigenesis RASSF1A elicits apoptosis through an MST2 pathway directing proapoptotic transcription by the p73 tumor suppressor protein Expression of Yes-associated protein in common solid tumors Oncogenic cooperation and coamplification of developmental transcription factor genes in lung cancer Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon Emerging role of Hippo pathway in gastric and other gastrointestinal cancers The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis AEG-1/MTDH/LYRIC in liver cancer Evasion of anti-growth signaling: A key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds.Small-molecule SMAC mimetics as new cancer therapeutics Emerging patterns of somatic mutations in cancer The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment A mouse stromal response to tumor invasion predicts prostate and breast cancer patient survival An orthotopic mouse model of hepatocellular carcinoma with underlying liver cirrhosis.Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog Structural insights into the YAP and TEAD complex Structural basis of YAP recognition by TEAD4 in the Hippo pathway Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy Emerging evidence on the role of the Hippo/YAP pathway in liver physiology and cancer

P2860

Q24170091-8729E6FA-1417-42D9-9793-44D01FC03959 Q24289539-85016D63-C971-4E7D-9CC2-EFFDC7C96B87 Q24293710-7093E1DB-B2D9-4EF0-A3FF-8E261A210721 Q24294906-10736788-9971-4931-85CF-1F5FDF4072FA Q24297998-49BEA422-D0E2-46E7-AC68-E89863FDCDC2 Q24298339-FCB30BFA-F584-4E51-A6B2-0F54DE28CF5E Q24299106-67CA0C5C-15AA-4553-906C-D20E6E3A5A9C Q24300770-DAE87C38-D040-401B-85B1-2827DCCBEBA0 Q24304338-53BB52CE-2B5C-4538-B44E-9DC8A6BCBC04 Q24306110-00E84FDC-C437-430D-A07D-6EDC320B12F4 Q24306274-70C710B4-F258-42C2-96E9-F06D802E24CB Q24306795-866DC068-7FF8-40BC-A534-5C3D1D2ABF48 Q24316181-76063CB6-9C30-4B82-8F67-D888D129A331 Q24318575-CB0CA6C3-11F6-4B41-9469-8D773306FFB8 Q24320328-DE996C09-775F-4F03-9177-FD7D1A44CBAE Q24323326-FBBBFDCA-1F6F-4FDD-A04B-A06D7FC39461 Q24336045-3934B449-D88F-4219-A47B-9B4DE4665C8E Q24570128-0884DD29-DC74-43E9-89AB-E93A03C68D65 Q24603986-844E756E-778C-47DD-AAC5-A54AD4BFD384 Q24612471-817B9B79-1708-4F66-80B3-A5A46837651E Q24623055-16ED11F6-FB0F-4084-A1F8-EF628716A319 Q24646374-2A25206D-F6EF-4A58-A207-1B745296CBC9 Q24648062-0F9E6956-63CD-45A5-88A3-F13EE325EA2F Q24657592-9FE48F36-5DAA-41DC-B76B-CB8554841256 Q24678477-84C1BFCB-5569-46A6-97DB-E3586A110EB9 Q24682018-8D29FBE1-0CB2-4FA3-AA63-185A095FE53F Q26774473-9E73C6FF-6C64-4B79-B3FC-57FEB6FB1B76 Q26775126-4AA61FBD-3FA3-4D12-91A0-8FBC34B44C2C Q26822570-61A93E92-8DF5-4E41-9DA6-7391EF992685 Q26827810-35212B1C-0F1B-4C89-8678-D41D57C611E7 Q26864204-11C6C518-1E87-4663-8E8C-5537CAA31E30 Q27014126-178884FB-11C1-404F-BCFD-46C831CC5A33 Q27025661-24A02330-BA4D-4BE9-9060-F4EF0B82C79B Q27303204-A9EE45F7-0E9C-4BB0-A69C-F9BF9B8F8F7A Q27310334-D2396C8B-0644-4C42-BE08-AD4E8AC32042 Q27487860-94B0514E-FE0F-4301-9409-9D94E96A7529 Q27659386-A23E1246-B05E-4252-A87A-F07F350521E8 Q27659390-4ACA5E6E-8029-4087-A7F8-964CEAB9CBFD Q28078129-E23F105D-3D83-4AC6-9F61-58CAB251B061 Q28086905-5D1D67F2-E4BB-48E1-A36C-6AA542A6AEE4

P2860

Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach

http://www.wikidata.org/entity/Q24633776

description

2006 nî lūn-bûn

@nan

2006 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Identification and validation ...... tegrative oncogenomic approach

@ast

Identification and validation ...... tegrative oncogenomic approach

@en

Identification and validation ...... tegrative oncogenomic approach

@nl

type

label

Identification and validation ...... tegrative oncogenomic approach

@ast

Identification and validation ...... tegrative oncogenomic approach

@en

Identification and validation ...... tegrative oncogenomic approach

@nl

prefLabel

Identification and validation ...... tegrative oncogenomic approach

@ast

Identification and validation ...... tegrative oncogenomic approach

@en

Identification and validation ...... tegrative oncogenomic approach

@nl

P1433

Q24633776-6A00FAA8-6051-4908-8630-E17B33CA67FE

P1476

Q24633776-12FDA619-20D4-43B7-9CBE-A150B2744EBF

P2093

Q24633776-10B3191B-D947-4EDC-9BCE-33999E4BD27C

Q24633776-4C1CAA06-EC96-4E38-8B0A-0248485BF2F7

Q24633776-50B1B020-C5AB-481C-9196-B4C43AC3D005

Q24633776-5F18FE4F-DA2C-40F8-8DCE-33DB983FDE25

Q24633776-9F33AD12-EBB5-4561-A391-42959FF2ABDA

Q24633776-B6593039-6A05-4FE3-9007-15133208FFA0

Q24633776-B7827CC8-3903-4861-A0E5-7FA5DE6486CB

Q24633776-E0E5AF89-BCC4-48F7-B5E7-1E4349B3AE83

P2860

Q24633776-0ADCBE0B-5D01-4143-9BA7-E41D758B48A1

Q24633776-0D453D36-45B4-4DB5-8A3E-14A9812AD0F0

Q24633776-140CB208-8300-4EB4-9863-E1E2A64548EA

Q24633776-19F2253E-B580-4D67-AFDD-470C8EBE4887

Q24633776-205F1E02-1830-4099-A4E8-5033E63E08AF

Q24633776-21ED21B8-9190-4C48-AB81-947B29218EBC

Q24633776-230558F9-1225-4578-995B-553C3CE8C089

Q24633776-310F6E8B-35A8-4BA9-8D6D-3740C79197D2

Q24633776-3221F45E-13AA-4E75-A6D5-4823C4AA76A2

Q24633776-33088782-19F6-4E72-B9DD-DB36670CD743

P304

Q24633776-9F2AE42A-2458-4968-8B74-4FECFE2A8710

P31

Q24633776-6715686C-BB9B-4D7F-8047-E7FC10B872D8

P3181

Q24633776-948DB986-B2F0-4669-AB49-80B239542093

P356

Q24633776-6D5F5E26-A651-4010-8640-224693E0AAB1

P407

Q24633776-3D117F93-7468-44D8-9A64-C370CB3B6FBF

P433

Q24633776-3A2C1BED-5A0B-47A8-974B-25EB35208985

P478

Q24633776-18017FCD-EF83-4E4D-9462-28514DFE8D0C

P50

Q24633776-07176223-7FEB-45C7-8613-0C07550CE9DF

Q24633776-21DA3C30-3175-4026-915E-3DE76A15B741

Q24633776-4FAE3B2F-321F-425B-9EF4-04F8E254EB21

Q24633776-6F7C4CCD-3BDB-43FD-9224-434EF69D7B34

Q24633776-7119CC67-AE12-4202-AB24-D618330459D5

Q24633776-7C7F95E2-16F2-49B4-A5AB-778B98222781

Q24633776-8CF3BE2A-AE57-4EB0-9FD9-70DCEFA93BFE

P577

Q24633776-6B0F651A-5169-4BE4-B634-A22EB8F429E4

P5875

Q24633776-F48E00CB-07E8-41F2-887B-F23A2E50EEF0

P698

Q24633776-6343FFD5-5D6C-48C6-B5FE-3535B3211ED0

P932

Q24633776-D046535E-AA8A-4489-A1D4-60D5DFC2B10E

P3181

P356

J.CELL.2006.05.030

P1433

P1476

Identification and validation ...... tegrative oncogenomic approach

@en

P2093

Lars Zender

http://www.w3.org/2001/XMLSchema#string

Mona S Spector

http://www.w3.org/2001/XMLSchema#string

Peer Flemming

http://www.w3.org/2001/XMLSchema#string

Robert Lucito

http://www.w3.org/2001/XMLSchema#string

Scott Powers

http://www.w3.org/2001/XMLSchema#string

Scott W Lowe

http://www.w3.org/2001/XMLSchema#string

Sheung-Tat Fan

http://www.w3.org/2001/XMLSchema#string

Wen Xue

http://www.w3.org/2001/XMLSchema#string

P2860

The Hallmarks of Cancer

Physical interaction with Yes-associated protein enhances p73 transcriptional activity

Molecular cloning of Porimin, a novel cell surface receptor mediating oncotic cell death

IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases

A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator.

Comprehensive genome sequence analysis of a breast cancer amplicon

Mutations of the BRAF gene in human cancer

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1

Representational oligonucleotide microarray analysis: a high-resolution method to detect genome copy number variation

P304

1253-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1261223

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CELL.2006.05.030

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

Carlos Cordon-Cardo

P577

2006-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6969535

http://www.w3.org/2001/XMLSchema#string

P698

16814713

http://www.w3.org/2001/XMLSchema#string

P932

3026384

http://www.w3.org/2001/XMLSchema#string